Healthtech funding in H1 2012

European Healthtech startup funding raised during H1 2012.

In H1 2012, 35 European Healthtech companies closed 36 funding rounds and raised €185M in equity funding (excluding debt and grants), down 39.3% versus H1 2011. UK led by capital raised, and Italian Angels for Growth was the most active investor. Data as of 6 Nov 2026.

Equity funding

€185M

-39.3% vs H1 2011 · excl. debt & grants

Funding rounds

-12.2% vs H1 2011

Companies

Top country

Rank among sectors

8.3% of sector funding

Top-10 round share

78.3%

of disclosed capital

Funding by month

€ raised vs rounds, by month

Data table

	Funding	Rounds
Jan	€21M	11
Feb	€22M	4
Mar	€8.6M	2
Apr	€3.7M	3
May	€119M	11
Jun	€14M	5

Top countries

by € raised

Data table

	Healthtech — top countries by capital, H1 2012
UK	€59M
Netherlands	€52M
France	€16M
Israel	€16M
Denmark	€11M
Switzerland	€9.1M
Sweden	€7.8M
Germany	€7.2M

Stage mix

by € raised

Data table

	Healthtech — stage mix, H1 2012
Series D+	€57M
Growth/Late	€39M
Early VC	€22M
Series B	€22M
Other	€14M
Series C	€12M
Series A	€12M
Seed	€8.3M
Grant	€2.7M

Top deals

largest disclosed rounds in H1 2012

Company	Stage	Date	Amount
Agendia	Series D+	May 2012	€49M
Oxford Nanopore Technologies	Growth/Late	May 2012	€39M
Egalet	Series B	May 2012	€11M
GlySure	Series C	Jan 2012	€8.4M
Pharnext	Other	Feb 2012	€8.0M
BONESUPPORT	Early VC	Jun 2012	€7.8M
Gamida Cell	Series D+	May 2012	€7.6M
Numares	Series B	Feb 2012	€7.2M
Enterome	Series A	Mar 2012	€5.0M
Simplee	Series A	May 2012	€4.5M
CartiHeal	Early VC	Feb 2012	€3.8M
Spinelab	Series C	May 2012	€3.7M
Abingdon Health	Early VC	Mar 2012	€3.6M
Aleva Neurotherapeutics	Series B	Apr 2012	€3.3M
Alize Pharma	Seed	Jun 2012	€3.3M

View all 36 Healthtech deals in H1 2012 →

Top investors

most active in H1 2012, by deal count

← All 2012 Healthtech funding